Alzheimer's Disease Cooperative Study (ADCS) — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). ADNI-GO seeks to define and characterize the mildest symptomatic phase of AD, referred to in this study as early amnestic MCI (EMCI). This information will aid in the early detection of AD, and in measuring the effectiveness of treatments in future clinical trials.	Alzheimer	À vérifier	Ralentissement de la progression + Traitement symptomatique	United States, Canada	À vérifier
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). ADNI-GO seeks to define and characterize the mildest symptomatic phase of AD, referred to in this study as early amnestic MCI (EMCI). This information will aid in the early detection of AD, and in measuring the effectiveness of treatments in future clinical trials.	Alzheimer	À vérifier	Ralentissement de la progression + Traitement symptomatique	United States, Canada	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.